Stay current with the latest press releases from within the industry.
Release issued 14th January 2010
Tampa, FL -- (Business Wire) - January 12, 2010 -- UTEK Corporation (NYSE Amex: UTK), a leading IP licensing and innovation services company, is pleased to announce a new pricing model for its Pharmalicensing online service; the pricing will be effective starting January 13th. UTEK's new Pay-per-Click pricing will create further market efficiencies for the Company's leading online licensing and partnering platform for the pharmaceutical industry. The pricing will provide additional opportunities for buyers and sellers to access the platform, and create a larger online IP marketplace. Pharmalicensing.com currently directs more than 190,000 visitors each month to emerging partnering opportunities posted by companies worldwide.
"In 2009, we spent considerable effort listening to our clients on how we might serve the marketplace better. I believe this pricing change will further extend our lead and continue to make our marketplace the most efficient and highly trafficked online licensing platform in the pharmaceutical sector." Mark McBride, Managing Director of UTEK Pharmalicensing continues, "Our Pay-per-Click option is intended to remove pricing barriers for users of our service, increasing our base of potential clients. We continue to take as much risk as possible out of our clients' partner search process, and offer our visitors more opportunities to fill their drug pipelines."
All new clients will be eligible for the pricing structure, which will enable companies to post their profile and only pay for qualified traffic. Pay-per-Click clients will pay only for the partnering opportunities or potential partner click-throughs they receive. The Company plans to expand the new pricing model to its Medical Device Licensing platform as well as additional licensing platforms to be launched in 2010. For more information please visit:
www.pharmalicensing.com or www.utekcorp.com
About UTEK Corporation
UTEK® is a leading global IP licensing and innovation services company. UTEK's services enable its clients to enhance their innovation capabilities, rapidly source externally developed technologies, create value from their intellectual property and gain foresight into marketplace and technology developments that could affect their business. For more information about UTEK, please visit its website at www.utekcorp.com.
Certain matters discussed in this press release are "forward-looking statements." These forward looking statements can generally be identified as such because the context of the statement will include words such as UTEK "expects," "should," "believes," "anticipates" or words of similar import. Certain factors could cause actual results to differ materially from those projected in these forward looking statements and these factors are identified from time to time in our filings with the Securities and Exchange Commission. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. This press release is available on UTEK's website www.utekcorp.com
If you want to find out more about the company visit Pharmalicensing profile.
(28th January 2010) New collaboration presents big opportunities for UK SMEs
(4th January 2008) UTEK Corporation Acquires Pharmalicensing, Ltd.
Clients in focus...